Browse #arix

Arix Bioscience Final Results, eEnergy Interims Results and Glen Goodman on Crypto

Arix Bioscience, Alba Mineral Resources and Vadim Alexander on Polarean Imaging

Arix Bioscience, Amryt Pharma and Paul Hill on 5 Stocks to Follow

Arix Bioscience, Vadim Alexandre on Synairgen and Glen Goodman

Arix Bioscience, Russ Mould on the Fed & Paul Hill on Boohoo

Arix Bioscience and Glen Goodman on the Markets, Gold and Bitcoin

Live Company Group, Arix Bioscience and Pires Investments

Arix Bioscience and Vadim Alexandre on Novacyt, Genedrive, Omega Diagnostics & Avacta

Arix Bioscience and Equatorial Mining & Exploration

Gfinity, Arix Bioscience and Meastrano

Arix Bioscience and Shield Therapeutics

Audioboom, Polarean and Arix Bioscience

Robert Lyne Chief Operating Officer and GC at Arix Bioscience discusses the highlights from their Final Results.

Jonathan Tobin, MD of Arix Bioscience discusses one of their portfolio companies, Artios Pharma, that's announced global strategic collaboration with Merck worth $7bn

Jonathan Tobin, Managing Director Arix Bioscience discusses Merck's $2.75 billion acquisition of VelosBio.